Pluristem Therapeutics, Inc. (PSTI): Price and Financial Metrics

Pluristem Therapeutics, Inc. (PSTI): $1.50

0.00 (0.00%)

POWR Rating

Component Grades













Add PSTI to Watchlist
Sign Up

Industry: Biotech



in industry

PSTI Stock Price Chart Interactive Chart >

Price chart for PSTI

PSTI Price/Volume Stats

Current price $1.50 52-week high $4.55
Prev. close $1.50 52-week low $1.31
Day low $1.46 Volume 96,100
Day high $1.53 Avg. volume 972,264
50-day MA $1.80 Dividend yield N/A
200-day MA $2.22 Market Cap 48.52M

Pluristem Therapeutics, Inc. (PSTI) Company Bio

Pluristem Therapeutics Inc. operates as a bio-therapeutics company in Israel. The company focuses on the research, development, clinical trial, and manufacture of cell therapeutics products and related technologies for the treatment of various ischemic and inflammatory conditions. The company was founded in 2001 and is based in Haifa, Israel.

PSTI Latest News Stream

Event/Time News Detail
Loading, please wait...

PSTI Latest Social Stream

Loading social stream, please wait...

View Full PSTI Social Stream

Latest PSTI News From Around the Web

Below are the latest news stories about Pluristem Therapeutics Inc that investors may wish to consider to help them evaluate PSTI as an investment opportunity.

15 Worst Stock Picks of Cathie Wood

In this article, we discuss the 15 worst stock picks of Cathie Wood. If you want to skip our detailed analysis of these stocks, go directly to the 5 Worst Stock Picks of Cathie Wood. Cathie Wood, the chief ARK Investment Management, is often hailed as the champion of “disruptive innovation” at the stock market. […]

Yahoo | January 21, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

I hope you enjoyed the long weekend, but it's time to get back into investing with the biggest pre-market stock movers for Tuesday!

William White on InvestorPlace | January 18, 2022

PSTI, BLRX and BBIG among pre-market gainers

Mainz Biomed (MYNZ) +14%. Vinco Ventures (BBIG) +13%. Digital World Acquisition (DWACW) +11%. Pluristem Therapeutics (PSTI) +10%

Seeking Alpha | January 18, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Welcome back, trader!

William White on InvestorPlace | January 10, 2022

Pluristem jumps on collaboration with Tnuva to develop cultured cell-based food products

Pluristem Therapeutics (PSTI) and Tnuva Group, Israel’s largest food producer, announce the launch of an innovative collaboration to develop, manufacture and commercialize…

Seeking Alpha | January 10, 2022

Read More 'PSTI' Stories Here

PSTI Price Returns

1-mo -14.29%
3-mo -11.24%
6-mo N/A
1-year -60.53%
3-year -77.60%
5-year -89.29%
YTD 2.74%
2021 -79.35%
2020 79.44%
2019 -50.13%
2018 -42.75%
2017 -3.50%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.5898 seconds.